Bayer Pharmaceuticals accelerates innovations for patients
LifeProNow
MARCH 27, 2023
Kerendia is already approved in major markets in chronic kidney disease (CKD) associated with type 2 diabetes. Bayer works on leveraging all the possibilities of the technologies while fully integrating all regulatory and bioethical requirements.” Bayer has exclusive worldwide marketing rights for this product including the U.S.
130 
Let's personalize your content